Department of War Pharmacy Uniform Formulary Blanket Purchase Agreement and Additional Discount Program

The Department of War seeks to establish Uniform Formulary Blanket Purchase Agreements and Additional Discount Program Agreements for pharmaceutical agents. The agency will consider clinical and cost effectiveness in its selection process. The agency is reviewing newly approved drugs for placement on the Uniform Formulary in February 2027. These include Atebrioz, Emcitate, Hibsago, Juvmo, and Zegfrovy. A Request for Quotation (RFQ) has been issued to obtain quotes from industry for pharmaceutical agents. Details regarding instructions, deadlines, and points of contact are provided in RFQ HT9402-27-Q-9102. A pre-quotation teleconference is scheduled for November 17, 2026. Responses to clinical questions must be submitted via email no later than the date specified in Part 2.3.2.